Marc Swidergall
- Infectious Diseases top 2%
- Epidemiology top 5%
- Molecular Biology
- Immunology top 10%
- Microbiology top 2%
- Co-authors
- Scott G. FillerNorma V. SolisJoachim F. ErnstMichail S. LionakisSarah L. GaffenAshraf S. IbrahimVincent M. BrunoQuynh T. Phan
- Topics
- Antifungal resistance and susceptibility (23 papers)Fungal Infections and Studies (16 papers)Antimicrobial Peptides and Activities (4 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Marc Swidergall
30 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 91
- Infectious Diseases 902
- Epidemiology 578
- Molecular Biology 334
- Immunology 224
- Microbiology 184
Countries citing papers authored by Marc Swidergall
This map shows the geographic impact of Marc Swidergall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Swidergall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Swidergall more than expected).
Fields of papers citing papers by Marc Swidergall
This network shows the impact of papers produced by Marc Swidergall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Swidergall. The network helps show where Marc Swidergall may publish in the future.
Co-authorship network of co-authors of Marc Swidergall
This figure shows the co-authorship network connecting the top 25 collaborators of Marc Swidergall. A scholar is included among the top collaborators of Marc Swidergall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Swidergall. Marc Swidergall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 6 | |
| 3 | 35 | |
| 4 | 32 | |
| 5 | 6 | |
| 6 | 17 | |
| 7 | 53 | |
| 8 | 41 | |
| 9 | 72 | |
| 10 | 19 | |
| 11 | 38 | |
| 12 | 48 | |
| 13 | 38 | |
| 14 | 39 | |
| 15 | 3 | |
| 16 | 3 | |
| 17 | 49 | |
| 18 | 87 | |
| 19 | 133 | |
| 20 | 68 |
About Marc Swidergall
Marc Swidergall is a scholar working on Infectious Diseases, Microbiology and Applied Microbiology and Biotechnology, having authored 31 papers that have together received 1.3k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (23 papers), Fungal Infections and Studies (16 papers) and Antimicrobial Peptides and Activities (4 papers). The work is most often cited by research in Infectious Diseases (902 citations), Microbiology (184 citations) and Periodontics (106 citations). Marc Swidergall has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Scott G. Filler, Norma V. Solis, Joachim F. Ernst, Michail S. Lionakis, Sarah L. Gaffen, Ashraf S. Ibrahim, Vincent M. Bruno, Quynh T. Phan, Salomé LeibundGut‐Landmann and Akash Verma. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.